PharmaCielo Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PCLO.V research report →
Companywww.pharmacielo.com
PharmaCielo Ltd. , together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software.
- CEO
- Marc Lustig
- IPO
- 2019
- Employees
- 268
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $18.80M
- P/E
- -4.13
- P/S
- 7.20
- P/B
- -1.22
- EV/EBITDA
- -37.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 28.97%
- Op Margin
- -146.43%
- Net Margin
- -174.39%
- ROE
- 35.85%
- ROIC
- -116.13%
Growth & Income
- Revenue
- $2.61M · -24.97%
- Net Income
- $-4,553,396 · 50.19%
- EPS
- $-0.03 · -151.00%
- Op Income
- $-3,823,484
- FCF YoY
- 48.25%
Performance & Tape
- 52W High
- $0.17
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.06
- Beta
- 0.38
- Avg Volume
- 56.32K
Get TickerSpark's AI analysis on PCLO.V
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PCLO.V Coverage
We haven't published any research on PCLO.V yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PCLO.V Report →